- Relationship of Treatment-Related Cytopenias and Response to Lenalidomide in Patients With Lower-Risk Myelodysplastic Syndromes
[作者：Sekeres, MA; Maciejewski, JP; Giagounidis, AAN; Wride, K; Knight, R; Raza, A; List, AF,期刊：Journal of clinical oncology, 页码：5943-5949 , 文章类型： Article，,卷期：2008年26-36]
- PurposePatients with myelodysplastic syndromes ( MDS) often require treatment with growth factors ( GFs) or non-GF therapies. One non-GF drug, lenalidomide, is particularly effective at achieving transfusion independence...
- Effect of BRCA1 Haplotype on Survival of Non-Small-Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy
[作者：Kim, HT; Lee, JE; Shin, ES; Yoo, YK; Cho, JH; Yun, MH; Kim, YH; Kim, SK; Kim, HJ; Jang, TW; Kwak, SM; Kim, CS; Ryu, JS,期刊：Journal of clinical oncology, 页码：5972-5979 , 文章类型： Article，,卷期：2008年26-36]
- PurposeTo determine whether germ-line variations in BRCA1 affect outcome in non-small-cell lung cancer ( NSCLC) patients treated with platinum combination chemotherapy.Patients and MethodsWe evaluated the associations of...
- Self-Reported Practices and Attitudes of US Oncologists Regarding Off-Protocol Therapy
[作者：Peppercorn, J; Burstein, H; Miller, FG; Winer, E; Joffe, S,期刊：Journal of clinical oncology, 页码：5994-6000 , 文章类型： Article，,卷期：2008年26-36]
- Purpose Investigational cancer therapies being tested in clinical trials may be available outside of trials, or off-protocol (OPRx). We evaluated the practices and attitudes among US oncologists with regard to this contr...
- Surprised by Hope
[作者：Francis, PA,期刊：Journal of clinical oncology, 页码：6001-6002 , 文章类型： Article，,卷期：2008年26-36]
- Providing and maintaining hope for patients with incurable cancer is something that medical oncologists recognize as important. Yet the fine line that we frequently tread between giving a realistic prognosis to facilitat...
- Primary Cardiac Lymphoma Presenting As Sick Sinus Syndrome
[作者：Motto, A; Ballo, P; Zito, D; Cadenotti, L; Moroni, M; Dessanti, P; Fedeli, F,期刊：Journal of clinical oncology, 页码：6003-6005 , 文章类型： Article，,卷期：2008年26-36]
-
- Phase I/II Study of Ipilimumab for Patients With Metastatic Melanoma
[作者：Weber, JS; O'Day, S; Urba, W; Powderly, J; Nichol, G; Yellin, M; Snively, J; Hersh, E,期刊：Journal of clinical oncology, 页码：5950-5956 , 文章类型： Article，,卷期：2008年26-36]
- PurposeThe primary objective of this phase I/II study was to determine the safety and pharmacokinetic profile of either transfectoma- or a hybridoma-derived ipilimumab. Secondary objectives included determination of a ma...
- Risk-Adapted Salvage Treatment With Single or Tandem Autologous Stem-Cell Transplantation for First Relapse/Refractory Hodgkin's Lymphoma: Results of the Prospective Multicenter H96 Trial by the GELA/SFGM Study Group
[作者：Morschhauser, F; Brice, P; Ferme, C; Divine, M; Salles, G; Bouabdallah, R; Sebban, C; Voillat, L; Casasnovas, O; Stamatoullas, A; Bouabdallah, K; Andre, M; Jais, JP; Cazals-Hatem, D; Gisselbrecht, C,期刊：Journal of clinical oncology, 页码：5980-5987 , 文章类型： Article，,卷期：2008年26-36]
- PurposeA prospective multicenter trial evaluated a risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation ( ASCT) for 245 Hodgkin's lymphoma ( HL) patients who experience treatment fail...
|